Professor Raina MacIntyre, head of the biosecurity program at the Kirby Institute at the University of NSW, said last week that the AstraZeneca vaccine may protect “against death and hospitalisation, but may not protect well against infection”.

“I do not believe the AstraZeneca vaccine – based on published phase 3 trial results – will be efficacious enough for herd immunity,” she said. READ MORE